Indian Railways implementing Kavach system to prevent train collisions, with installation on key routes by 2030.

Company acquiring former Butler prison seeks Wayne County IDA assistance for redevelopment ...

Eli Lilly (NYSE: LLY) sells a broad range of pharmaceuticals treating various diseases, but one portfolio in particular has ...

Spanning 176 weeks of treatment, the Phase III trial evaluated the efficacy and safety of tirzepatide in adults without type ...

The National Toy Hall of Fame in Rochester, New York, now includes 87 toys, as the museum has been inducting toys to the ...

Three buildings on Commercial Street have been a pain to village officials for long enough. Now that they’re slated for ...

Omega Therapeutics is halting work on its only clinical-stage candidate as part of a strategic refocus centered on three ...

A $3 billion mixed-use project is advancing in Frisco, with plans to include a $400 million Las Vegas-style hotel among its ...

Daré Bioscience ( (DARE) ) has released its Q3 earnings. Here is a breakdown of the information Daré Bioscience presented to its investors.

As part of this strategic shift, MICL Group has divested from phase 3 of the project located near Dahisar in Mira road. This divestment represents a strategic move to focus more efficiently towards ...

Islamic Resistance targeted a gathering of the “Israeli” enemy forces in the eastern outskirts of the town of Markaba at 7:30 ...

A phase 3 trial found that Eli Lilly's tirzepatide significantly reduced the risk of progression to Type 2 diabetes in prediabetic adults over a three-year period. Nearly 99% of individuals treated ...